2,3-dibenzylbutane-1,4-diol has been researched along with lignans in 3 studies
Studies (2,3-dibenzylbutane-1,4-diol) | Trials (2,3-dibenzylbutane-1,4-diol) | Recent Studies (post-2010) (2,3-dibenzylbutane-1,4-diol) | Studies (lignans) | Trials (lignans) | Recent Studies (post-2010) (lignans) |
---|---|---|---|---|---|
8 | 0 | 0 | 7,024 | 95 | 4,172 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 3 (100.00) | 18.2507 |
2000's | 0 (0.00) | 29.6817 |
2010's | 0 (0.00) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Hirano, T; Homma, M; Hosaka, K; Mitsuhashi, H; Naito, T; Oka, K | 1 |
Fukuoka, K; Hirano, T; Hosaka, K; Matsumoto, Y; Mitsuhashi, H; Naito, T; Oka, K | 1 |
Abe, M; Inoue, M; Morikawa, M; Tsuboi, M; Yamauchi, Y | 1 |
3 other study(ies) available for 2,3-dibenzylbutane-1,4-diol and lignans
Article | Year |
---|---|
Ion-sparing diuresis by 2,3-dibenzylbutane-1,4-diol, a synthetic mammalian-lignan derivative.
Topics: Animals; Benzyl Compounds; Chlorides; Diuretics; Furans; Furosemide; Ion Exchange; Lignans; Male; Mice; Mice, Inbred BALB C; Natriuresis; Potassium; Rats; Rats, Inbred Strains; Sodium | 1991 |
Antiproliferative activity of mammalian lignan derivatives against the human breast carcinoma cell line, ZR-75-1.
Topics: 4-Butyrolactone; Adenosine Triphosphatases; Animals; Benzyl Compounds; Breast Neoplasms; Butylene Glycols; Cell Division; Cell Line; Dogs; Dose-Response Relationship, Drug; Fluorouracil; Humans; Kidney Cortex; Lethal Dose 50; Lignans; Ouabain | 1990 |
Priming effect of 2,3-dibenzylbutane-1,4-diol (mammalian lignan) on superoxide production in human neutrophils.
Topics: Alkaloids; Benzyl Compounds; Calcimycin; Calcium; Cell Compartmentation; Diglycerides; Humans; In Vitro Techniques; Lignans; Lignin; N-Formylmethionine Leucyl-Phenylalanine; Neutrophils; Protein Kinase C; Staurosporine; Sulfonamides; Superoxides; Trifluoperazine | 1990 |